<DOC>
	<DOCNO>NCT02925663</DOCNO>
	<brief_summary>The purpose study establish feasibility , accessibility , acceptability , preliminary efficacy individually-tailored intervention improve EF adolescent epilepsy ( EFI-E ) .</brief_summary>
	<brief_title>Web-based Intervention Improve Executive Functioning Teens With Epilepsy</brief_title>
	<detailed_description>Epilepsy common childhood condition affect approximately 326,000 youth United States . Adolescents epilepsy significant risk poor social academic outcome , neurobehavioral comorbidities ( i.e. , internalize externalize symptom ) , poor treatment adherence . Studies show one potential reason poor outcome deficit executive functioning ( EF ) , define skill necessary goal-directed complex activity , include problem-solving , initiation , monitoring , organization , planning , self-regulation work memory . EF deficit document 1/3 youth epilepsy , 3 time prevalence healthy youth . Evidence-based intervention improve EF could play critical role prevent adverse outcome ( e.g. , psychological comorbidities , non-adherence treatment regimen ) promote optimal function adolescent epilepsy ; however none exist vulnerable population . The aim current study establish feasibility , accessibility , acceptability , preliminary effect individually-tailored intervention improve EF adolescent epilepsy ( Executive Functioning Intervention-Epilepsy ; EFI-E ) . Thirty participant recruit least one clinically-elevated EF subscale least two at-risk subscale score ( &gt; 1 standard deviation mean ) parent Behavior Rating Inventory Executive Function ( BRIEFÂ® ) ) qualify EFI-E. EFI-E consist 10 web-based module address foundational EF skill . Each online module accompany videoconference therapist review skill problem solve around adolescent-identified goal . Baseline post-treatment questionnaire complete adolescent primary caregiver electronically-monitored adherence obtain throughout open trial . Participants trial 9 month .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Inclusion criterion Age 1317 year Diagnosis epilepsy Have least two subclinical ( &gt; 1 SD ; T score 6065 ) one clinicallyelevated BRIEF subscale ( T score &gt; 65 ) Primary caregiver consent adolescent assent participate study Exclusion criterion Diagnosis nonepilepsy medical disorder require daily medication exception asthma and/or allergy Diagnosis significant developmental disorder ( e.g . Autism ) Inability read speak English due questionnaire intervention develop English Family live great 100 mile away CCHMC If patient plan wean antiepileptic medication within next 6 month</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>executive functioning</keyword>
</DOC>